Pursuing our researches on quinolizidinyl derivatives of phenothiazine
and on the ground of antidepressive, diuretic, antianginal and antiar
rhythmic activities of several 10-(3-dialkylamino) propionylphenothiaz
ines (as chloracizine, moricizine, etc.), six 10-homolupinanoyl-2-R-ph
enothiazines were prepared and subjected to a broad pharmacological sc
reening with in vivo and in vitro assays. Most of these compounds exer
ted strong antiarrhythmic activity (compounds 1, 3 and 5 were comparab
le or superior to lidocaine and quinidine in three tests), calcium ant
agonism on guinea pig ileum and left atria, antagonism to smooth muscl
e contractile responses induced by several agents and inhibition of ra
bbit platelet aggregation induced by PAF and ADP. A few other activiti
es were characteristic of single compounds, as antagonism to central a
nd peripheral effects of oxotremorine 1, moderate antihypertensive act
ivity 5, local anesthetic activity and antagonism to substance P2, ant
iinflammatory activity with low or absent gastric irritation 2,3, powe
rful saluretic action 6, inhibition of arachidonate induced platelet a
ggregation 1 and antagonism to PAF induced mortality 1, 4. The last ac
tivity is very unusual and deserves further investigation. The capacit
y of compound 1 to displace specific ligands from several receptors wa
s also investigated. Significant binding for M(1) (IC50=0.03 mu M), M(
3) (IC50=10 mu M), sigma receptors and Na+ channels (IC50=1 mu M) were
evidentiated.